Decreased expression ofCUL5 might contribute to disease progression in CLL patients, as CUL5 is involved in regulating TP53 stability and ubiquitin-dependent control of apoptosis. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.